The specific deletion of hepatic Sirt1 impairs the fatty acid β-oxidation pathway, thereby heightening the susceptibility of mice to HFD-induced dyslipidemia, hepatic steatosis, inflammation, and ER stress [39,40]. This evidence concerns the gene SIRT1 and fatty liver disease.